PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan.

Autor: Suzuki, Ryo1 (AUTHOR) suzukir@tokyo-med.ac.jp, Amadid, Hanan2 (AUTHOR), Major‐Pedersen, Atheline3 (AUTHOR), Yabe, Daisuke4,5,6 (AUTHOR)
Zdroj: Journal of Diabetes Investigation. Aug2024, Vol. 15 Issue 8, p1047-1056. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje